These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30692860)
1. Multiple Sclerosis Functional Composite. Demir S Noro Psikiyatr Ars; 2018; 55(Suppl 1):S66-S68. PubMed ID: 30692860 [TBL] [Abstract][Full Text] [Related]
2. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503 [TBL] [Abstract][Full Text] [Related]
3. Functional clinical outcomes in multiple sclerosis: Current status and future prospects. Karabudak R; Dahdaleh M; Aljumah M; Alroughani R; Alsharoqi IA; AlTahan AM; Bohlega SA; Daif A; Deleu D; Amous A; Inshasi JS; Rieckmann P; Sahraian MA; Yamout BI Mult Scler Relat Disord; 2015 May; 4(3):192-201. PubMed ID: 26008936 [TBL] [Abstract][Full Text] [Related]
4. The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis. Brenton JN; Koshiya H; Woolbright E; Goldman MD Mult Scler J Exp Transl Clin; 2019; 5(2):2055217319846141. PubMed ID: 31065380 [TBL] [Abstract][Full Text] [Related]
5. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Ozakbas S; Cagiran I; Ormeci B; Idiman E J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626 [TBL] [Abstract][Full Text] [Related]
6. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary]. Mezei Z; Bereczki D; Csiba L; Csépány T Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882 [TBL] [Abstract][Full Text] [Related]
7. Improvement in the multiple sclerosis functional composite score by multi-function swing suspension training program. Sepehri Far S; Amiri B; Sahebozamani M; Ebrahimi HA Mult Scler Relat Disord; 2022 Nov; 67():104174. PubMed ID: 36174257 [TBL] [Abstract][Full Text] [Related]
8. Investigating the relationship between multiple sclerosis disability and driving performance: A comparative study of the multiple sclerosis functional composite and expanded disability status scale. Martínez-Ginés ML; Esquivel A; Hernández YH; Alvarez-Sala LA; Benito-León J Clin Neurol Neurosurg; 2024 Sep; 244():108431. PubMed ID: 39047389 [TBL] [Abstract][Full Text] [Related]
9. [Application of the Multiple Sclerosis Functional Composite in Debrecen]. Mezei Z; Bereczki D; Csiba L; Csépány T Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses. Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119 [TBL] [Abstract][Full Text] [Related]
11. The multiple sclerosis functional composite: a clinically meaningful measure of disability. Polman CH; Rudick RA Neurology; 2010 Apr; 74 Suppl 3():S8-15. PubMed ID: 20421572 [TBL] [Abstract][Full Text] [Related]
12. Paced visual serial addition test in multiple sclerosis. Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678 [TBL] [Abstract][Full Text] [Related]
13. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737 [TBL] [Abstract][Full Text] [Related]
14. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Patzold T; Schwengelbeck M; Ossege LM; Malin JP; Sindern E Acta Neurol Scand; 2002 Mar; 105(3):164-8. PubMed ID: 11886358 [TBL] [Abstract][Full Text] [Related]
15. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients. Pavsic K; Pelicon K; Ledinek AH; Sega S Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365 [TBL] [Abstract][Full Text] [Related]
16. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker. Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633 [TBL] [Abstract][Full Text] [Related]
17. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208 [TBL] [Abstract][Full Text] [Related]
18. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing. Strober L; Chiaravalloti N; Moore N; DeLuca J Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909 [TBL] [Abstract][Full Text] [Related]
19. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951 [TBL] [Abstract][Full Text] [Related]
20. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments]. Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]